Brooks Laboratories Q2 Results

  • BSE: 533543
  • NSE: BROOKS
  • ISIN: INE650L01011
  • Sector: Major Drugs
BSE
143.82.80 (1.99%)
Volume9.84 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
142.82.80 (2.00%)
Volume17.09 K
Updated: Mon 25 Nov, 2024 | 15:15:10
Today: 138.50
143.80
52-Wk: 72.51
185.15

Q2 Results Highlights

  • Total Income
    ₹20.79 Cr.
    (15.95%)
  • Operating Profit
    ₹1.08 Cr.
    (NA%)
  • Profit After Tax
    ₹-3.96 Cr.
    (64.22%)
  • Operating Margin
    5.19%
    (-1.04%)
Note: Comparison is on YoY basis

Quarterly - Brooks Laboratories Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 20.7915.70-%24.32-%
Selling/ General/ Admin Expenses Total 3.212.77-%2.65-%
Depreciation/ Amortization 0.430.44-%0.44-%
Other Operating Expenses Total 2.871.92-%2.49-%
Total Operating Expense 19.7116.12-%23.04-%
Operating Income 1.08-0.42-%1.27-%
Net Income Before Taxes -3.96-4.47-%-1.64-%
Net Income -3.96-4.47-%-1.64-%
Diluted Normalized EPS -1.51-1.79-%-0.64-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts